-
Posted by
Two Blokes Apr 15 -
Filed in
General
-
#TwoBlokesTrading
-
8 views
Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift in early Monday trading, after a potential competitor decided to cancel development of its GLP-1 drug.